$79.70
Use 95873 for electrical stimulation guidance during chemodenervation; use 95874 when needle EMG provides the guidance.
On this page
CMS RVU26D · Effective 2026-10-01
95873 Stimulation guidance Medicare reimbursement rates in Delaware
Electrical stimulation helps guide muscle targeting during chemodenervation, such as botulinum toxin treatment for focal spasticity or dystonia. Compare 95873 office and facility rates across CMS payment localities in Delaware.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for 95873 in Delaware?
Delaware has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$75.41
1 of 1 localities have a supported rate.
Payment area: Delaware
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Chemodenervation
About 95873: Electrical stimulation guidance for chemodenervation
Electrical stimulation helps guide muscle targeting during chemodenervation, such as botulinum toxin treatment for focal spasticity or dystonia.
Electrical stimulation guidance is used during chemodenervation to help identify or confirm the intended muscle or motor point while medication is delivered. Neurologists and physiatrists commonly use it when treating focal spasticity or dystonia with botulinum toxin, including in office-based procedures. The guidance supports target selection; it is not the chemodenervation injection itself.
Report 95873 only with the primary chemodenervation procedure; it is an add-on and is paid within that procedure’s global period. Documentation should identify the treated condition and muscles, the primary procedure, and the use of electrical stimulation for guidance. CMS identifies professional and technical components: modifier 26 represents the professional interpretation, modifier TC the technical service, and no modifier represents the global service.
CMS billing rules for 95873
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Diagnostic test with a professional component (modifier 26, interpretation) and a technical component (modifier TC, equipment and staff); billing without a modifier is the global service.
Where the value comes from
- Work RVU0.36 · 16%
- Practice expense (office) RVU1.91 · 84%
- Malpractice RVU0.01 · 0%
4.2K
Medicare services in 2024 · #1974 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
95873 compared with similar codes
Office rates for Delaware, from the same CMS release.
$139.84
64612 reports the chemodenervation treatment of specified cranial-nerve-supplied muscles; 95873 reports electrical stimulation guidance as an add-on.
$141.26
64616 reports chemodenervation of neck muscles. 95873 is the separate add-on for electrical stimulation guidance when used with a primary treatment.
Compare 95873 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Delaware →
Office / nonfacility
$75.41
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 95873 in Delaware.
PPRRVU2026_Oct_nonQPP.csv
12,609
- Code
- 95873
- Physician work
- 0.36
- Practice expense
- 1.91
- Malpractice
- 0.01
GPCI2026.csv
40
- Locality
- Delaware
- Physician work
- 1.005
- Practice expense
- 0.988
- Malpractice
- 0.899
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.36 | × 1.005 | 0.3618 |
| Practice expense | 1.91 | × 0.988 | 1.8871 |
| Malpractice | 0.01 | × 0.899 | 0.0090 |
| Total RVUs | 2.2579 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Delaware$75.41
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0.36 | 1.005 |
| Practice expense | 1.91 | 0.988 |
| Malpractice | 0.01 | 0.899 |
(0.36 × 1.005 + 1.91 × 0.988 + 0.01 × 0.899) × $33.4009 = $75.41
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
95873 billing questions
Can 95873 be reported by itself?
No. It is an add-on for electrical stimulation guidance and must be billed with the primary chemodenervation procedure.
How is 95873 different from 95874?
95873 describes electrical stimulation guidance. 95874 describes needle EMG guidance during chemodenervation.
What documentation supports 95873?
Document the chemodenervation service, the muscles treated, and that electrical stimulation was used to guide targeting.
Can modifier 26 or TC be used?
CMS identifies a professional component reported with modifier 26 and a technical component reported with modifier TC. Without either modifier, the claim represents the global service.
Is the guidance included in the primary procedure?
95873 is separately reported as an add-on when electrical stimulation guidance is performed with the primary chemodenervation service. Payment is within that primary procedure’s global period.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
12,60695872,,Ndl emg single fiber eltrd,A,,2.81,3.48,,3.48,NA,0.16,6.45,6.45,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,60795872,26,Ndl emg single fiber eltrd,A,,2.81,1.64,,1.64,,0.15,4.60,4.60,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,60895872,TC,Ndl emg single fiber eltrd,A,,0.00,1.84,,1.84,NA,0.01,1.85,1.85,1,XXX,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,66,0,99,0.00,0.00,0.00
12,60995873,,Guide nerv destr elec stim,A,,0.36,1.91,,1.91,NA,0.01,2.28,2.28,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,61095873,26,Guide nerv destr elec stim,A,,0.36,0.23,,0.23,,0.01,0.60,0.60,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
12,61195873,TC,Guide nerv destr elec stim,A,,0.00,1.68,,1.68,NA,0.00,1.68,1.68,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,03,0,99,0.00,0.00,0.00
12,61295874,,Guide nerv destr needle emg,A,,0.36,2.04,,2.04,NA,0.01,2.41,2.41,1,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
3704112,CO,01,COLORADO,1.012,1.064,0.781
3813102,CT,00,CONNECTICUT,1.020,1.077,1.210
3912202,DC,01,DC + MD/VA SUBURBS,1.054,1.178,1.113
4012102,DE,01,DELAWARE,1.005,0.988,0.899
4109102,FL,03,FORT LAUDERDALE,1.000,1.013,1.808
4209102,FL,04,MIAMI,1.000,1.041,2.529
4309102,FL,99,REST OF FLORIDA,1.000,0.956,1.503